You can check out the atherosclerotic cardiovascular disease (ASCVD) calculator here:
My 10 year risk is 4.7%, lifetime is 46%.
According to this I should not need to be on statins. Never follow anything I do, I'm stroke-addled.
Abstract
The
2013 American College of Cardiology/American Heart Association
Guideline on the Treatment of Blood Cholesterol to Reduce
Atherosclerotic Cardiovascular Risk in Adults was based on a systematic
review of randomized trials with atherosclerotic cardiovascular disease
(ASCVD) outcomes and meta-analyses of these trials published through
2011. With evidence of an ASCVD risk reduction benefit greatly
outweighing the potential for adverse effects, the guideline recommends
statin therapy for primary prevention in those with ≥7.5% 10-year ASCVD
risk and consideration of statin therapy in those with 5% to <7.5%
10-year ASCVD risk. Subsequent meta-analyses of the statin trials
support these recommendations and have additionally found a reduction in
total mortality in lower-risk subjects. Additional evidence from
imaging trials and epidemiologic studies suggests that initiation of
statin therapy earlier in the course of ASCVD could have the potential
to more effectively prevent age-related progression of atherosclerosis.
Given the high levels of suboptimal risk factors in adults and the
safety and availability of low-cost generic statins, a consideration of
all the available evidence strongly supports earlier intervention for
the primary prevention of ASCVD. In conclusion, earlier initiation of
statin therapy has the potential to have a large long-term impact on the
heavy burden of cardiovascular disease in the aging populations.
No comments:
Post a Comment